
    
      Hydrocortisone acetate 90 mg or placebo will be administered as a rectal suppository with a
      Sephure suppository applicator. Two arms of the study will receive different dosage regimens
      of hydrocortisone acetate, and the third arm will receive placebo. All subjects will
      administer the study drug twice a day; once in the morning and once in the evening for 28
      days.

      The study population will consist of male and non pregnant, non lactating females aged 18
      years and older with a confirmed diagnosis of active UC of the rectum.
    
  